Implementing Evidence-Based Nursing: Leadership and Organizational Change for Implementation (LOCI-FIN-P)

February 2, 2026 updated by: Jaakko Varpula

This study aims to find out whether a leadership and organizational development program called the LOCI (Leadership and Organizational Change for Implementation) strategy can help nurses and their managers use the best available research in everyday care. Using evidence-based practice.

Previous work in the region showed that nurses and their managers want to use evidence-based practices but face challenges, such as unclear processes, limited support, and differences in skills. The LOCI strategy has helped leaders in other countries improve how new practices are introduced and supported. This study will test a version of LOCI adapted for Finnish healthcare settings.

Nurse managers and staff from selected hospital and elder care units will:

Take part in leadership and training sessions. Receive individual and group mentoring. Work with their teams on plans that support introducing new, research-based ways of working.

Two evidence-based practices will be introduced:

In psychiatric units: A safety planning method to help prevent suicide among people receiving mental health care.

In elder care units: Better ways to identify and treat malnutrition among older adults.

The study involves:

Nurse managers Nursing staff Senior nurse leaders Specialist nurses who support the training

The study will run for one year. The LOCI program lasts nine months, followed by a three-month follow-up period.

Assessment:

How well the adapted LOCI strategy works in practice (for example, whether participants find it useful).

Whether leadership skills and workplace support for evidence-based practices improve.

Whether the new care practices (suicide safety planning and malnutrition prevention) are used more often and more effectively.

Participants will complete questionnaires, take part in interviews or group discussions, and researchers will review documentation and care records to understand how the changes progress.

The study may help improve leadership skills, strengthen support for evidence-based practice, and improve care for patients in both mental health and elder care settings. The results may also help other healthcare organizations adopt similar approaches.

The study follows strict ethical and data protection rules. Survey participation is voluntary, and all personal information will be handled securely and confidentially. The care practices being introduced are already recommended in Finland and are part of normal care.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jaakko Varpula, PhD
  • Phone Number: +358442784794
  • Email: jaheva@utu.fi

Study Contact Backup

  • Name: Riitta Askola, PhD
  • Phone Number: +358505715760
  • Email: raasko@utu.fi

Study Locations

      • Turku, Finland
        • Recruiting
        • The Wellbeing Services Country of Southwest Finland
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Nurse manager
  • Registered nurse
  • Practical nurse
  • Nurse director

Exclusion Criteria:

• Other healtcare professionals

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Leadership and Organizational Change for Implementation (LOCI)
LOCI (Leadership and Organizational Change for Implementation) is a structured leadership and organizational development strategy designed to help managers strengthen their skills in implementing evidence-based practices. It combines leadership training, individualized mentoring, and organizational support to create a workplace climate that makes it easier to adopt and sustain new, research-based ways of working.
LOCI (Leadership and Organizational Change for Implementation) is a structured leadership and organizational development strategy designed to help managers strengthen their skills in implementing evidence-based practices. It combines leadership training, individualized mentoring, and organizational support to create a workplace climate that makes it easier to adopt and sustain new, research-based ways of working.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability
Time Frame: 3months after start of intervention, 9 months (end of intervention)
Acceptability of Intervention Measure (AIM), 4-item, 5-point Likert Scale (1-5), Min score 5, Max score 20. Higher scores indicate greater acceptability.
3months after start of intervention, 9 months (end of intervention)
Appropriateness
Time Frame: 3months after start of intervention, 9 months (end of intervention)
Intervention Appropriateness Measure (IAM), 4-item, 5-point Likert scale (1-5), Min score 5, Max score 20. Higher scores indicate greater appropriateness.
3months after start of intervention, 9 months (end of intervention)
Feasibility of intervention
Time Frame: 3months after start of intervention, 9 months (end of intervention)
Feasibility of Intervention Measure (FIM), 4-item, 5-point Likert scale (1-5), Min score 5, Xax score 20. Higher scores indicate greater feasibility.
3months after start of intervention, 9 months (end of intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness to implementation leadership
Time Frame: Baseline, 3month, 8months, 3 month follow-up
Implementation leadership scale (ILS), 21-item, 5-point Likert scale (0-4). Min 0 and Max score 84. Higher scores indicate better implementation-supportive leadership.
Baseline, 3month, 8months, 3 month follow-up
Effectiveness to transformational leadership
Time Frame: Baseline, 3month, 8months, 3 month follow-up
Global Transformational Leadership Scale (GTL), 7-item, 5-point Likert Scale (1-5), Min 7, Max score 35, higher score indicate better outcome, more transformational leadership behaviours.
Baseline, 3month, 8months, 3 month follow-up
Effectiveness to implementation climate
Time Frame: Baseline, 3month, 8months, 3 month follow-up
Implementation Climate Scale (ICS), 27-item, 5-point Likert scale (0-4), Min 0, Max score 108, higher scores indicate better outcomes - stronger organizational climate supporting evidence-based practice implementation.
Baseline, 3month, 8months, 3 month follow-up
Effectiveness to evidence-based practice attitudes
Time Frame: Baseline, 3month, 8months, 3 month follow-up
The Evidence-based Practice Attitude Scale (EBPAS), 15-item, 5-point Likert Scale (0-4). Min 0, Max score 60, higher scores indicate better outcome, more positive atittudes towards evidence-based practice.
Baseline, 3month, 8months, 3 month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Anna Axelin, Professor, University of Turku, Department of Nursing Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

January 14, 2026

First Submitted That Met QC Criteria

January 22, 2026

First Posted (Actual)

January 30, 2026

Study Record Updates

Last Update Posted (Actual)

February 5, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified instrument-level data derived from questionnaires (ILS, GTL, ICS, EBPAS, AIM, IAM, FIM) completed by staff participants will be shared. These datasets will include item-level responses but will exclude any direct identifiers or variables that could reasonably enable re-identification.

IPD Sharing Time Frame

Instrument-level IPD will be made available upon publication of the main study findings.

IPD Sharing Access Criteria

Researchers may request access by contacting the principal investigators. Data will be shared through a secure repository after approval of a brief data-use proposal and signing a data-use agreement.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Leadership

Clinical Trials on Leadership and organizational change for implementation

Subscribe